These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20816372

  • 1. Safety of denosumab in giant-cell tumour of bone.
    Thomas D, Carriere P, Jacobs I.
    Lancet Oncol; 2010 Sep; 11(9):815. PubMed ID: 20816372
    [No Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of denosumab in giant-cell tumour of bone.
    Kyrgidis A, Toulis K.
    Lancet Oncol; 2010 Jun; 11(6):513-4. PubMed ID: 20522379
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Denosumab: a breakthrough in treatment of giant-cell tumour of bone?
    Balke M, Hardes J.
    Lancet Oncol; 2010 Mar; 11(3):218-9. PubMed ID: 20149737
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. More about osteonecrosis.
    Finkelman RD, Clemons M, Bouganim N.
    J Am Dent Assoc; 2011 Apr; 142(4):371-2; author reply 372-4. PubMed ID: 21454842
    [No Abstract] [Full Text] [Related]

  • 8. Denosumab-related osteonecrosis of the jaws.
    Kyrgidis A, Toulis KA.
    Osteoporos Int; 2011 Jan; 22(1):369-70. PubMed ID: 20306021
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. RANKL, denosumab, and giant cell tumor of bone.
    Thomas DM.
    Curr Opin Oncol; 2012 Jul; 24(4):397-403. PubMed ID: 22581354
    [Abstract] [Full Text] [Related]

  • 12. New oncology drugs and osteonecrosis of the jaw (ONJ).
    Migliorati CA, Covington JS.
    J Tenn Dent Assoc; 2009 Jul; 89(4):36-8; quiz 38-9. PubMed ID: 20102031
    [No Abstract] [Full Text] [Related]

  • 13. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I.
    Clin Cancer Res; 2012 Aug 15; 18(16):4415-24. PubMed ID: 22711702
    [Abstract] [Full Text] [Related]

  • 14. Denosumab: Excellent response of metastatic giant cell tumor of the bone.
    Ulas A, Bulent Akinci M, Silay K, Sendur MA, Sener Dede D, Yalcin B.
    J BUON; 2015 Aug 15; 20(2):666-7. PubMed ID: 26011370
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone.
    Gossai N, Hilgers MV, Polgreen LE, Greengard EG.
    Pediatr Blood Cancer; 2015 Jun 15; 62(6):1078-80. PubMed ID: 25556556
    [Abstract] [Full Text] [Related]

  • 18. Golden bullet-denosumab: early rapid response of metastatic giant cell tumor of the bone.
    Demirsoy U, Karadogan M, Selek Ö, Anik Y, Aksu G, Müezzinoglu B, Corapcioglu F.
    J Pediatr Hematol Oncol; 2014 Mar 15; 36(2):156-8. PubMed ID: 24072245
    [Abstract] [Full Text] [Related]

  • 19. Denosumab for bone metastases.
    Med Lett Drugs Ther; 2011 Jan 24; 53(1356):8. PubMed ID: 21252843
    [No Abstract] [Full Text] [Related]

  • 20. Denosumab an option for patients with bone metastasis from breast cancer.
    Barton MK.
    CA Cancer J Clin; 2011 Jan 24; 61(3):135-6. PubMed ID: 21532096
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.